My PCR
Create Account
Logo PCR

23 May 2019

Left main and multivessel diseaseStents, scaffolds and DCB

Ability to treat diabetic patients: DES + DCB strategy

Sponsored by Concept Medical

Chairpersons: R. Mehran, M. C. Morice, A. Mehta
Panellists: A. Abizaid, A. Colombo, A. Seth
SHOW MORE

Summary

Consult this session to get insights about the need for a dedicated drug eluting stent (DES), as well as the benefits of a DES+DCB strategy, for diabetes mellitus (DM) and acute MI (AMI) patients.

Learning Objectives

  • To understand and discuss the need for a dedicated DES for diabetes mellitus (DM) and acute MI (AMI) patients
  • To understand and learn benefits of DES+DCB strategy to provide uniform and homogenous drug delivery in patients with diabetes mellitus and acute MI
  • To learn about a DES with on label indication for diabetes mellitus and acute MI
Related Content
Share your work at PCR-CIT China Chengdu Valves 2025 Hostile left main calcific stenosis in HFrEF How to avoid using a new balloon for trapping?
Recommended for you
OPTION-STEMI What's the best way to reduce the cost of your #AictPCR badge? AICT-AsiaPCR: Call for Submissions is now open